Evidence map›Paper›PMID 24011073›Full record

ArticleCell metabolism2013

The REGγ proteasome regulates hepatic lipid metabolism through inhibition of autophagy.

Shuxian Dong, Caifeng Jia, Shengping Zhang, Guangjian Fan, Yubing Li, Peipei Shan, Lianhui Sun, Wenzhen Xiao, Lei Li, Yi Zheng and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 82 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Reciprocal REGOxidative medicine and cellular longevity · 2023
    Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 5 institutions in 3 countries.

Shuxian DongShanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, East China Normal University, Shanghai, 200241, China; Department of Molecular and Cellular Biology, Department of Medicine, The Dan L. Duncan Cancer Center, The Diabetes Research Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
Caifeng Jia
Shengping Zhang
Guangjian Fan
Yubing Li
Peipei Shan
Lianhui Sun
Wenzhen Xiao
Lei Li
Yi Zheng
Jinqin Liu
Haibing Wei
Chen Hu
Wen Zhang
Y Eugene Chin
Qiwei Zhai
Qiao Li
Jian Liu
Fuli Jia
Qianxing Mo
Dean P Edwards
Shixia Huang
Lawrence Chan
Bert W O'Malley
Xiaotao Li
Chuangui Wang
East China Normal University · CNBaylor College of Medicine · USChinese Academy of Sciences · CNGuangxi Medical University · CNUniversity of Ottawa · CA

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
REPRODUCTIVE HORMONES: BIOLOGICAL AND MOLECULAR ACTIONSR01HD008188 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI DAVID M LONARD, JOHN P LYDON · 1985 to 2026
$16.3M
Diabetes Endocrinology Research CenterP30DK079638 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI CHAN, LAWRENCE · 2008 to 2012
$6.4M
MODELS FOR ATHEROSCLEROSIS RESEARCHR01HL051586 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI CHAN, LAWRENCE · 1994 to 2014
$5.5M
Understanding the Roles of REGgamma in Anaplastic Thyroid Cancer ProgressionR01CA131914 · NCI · BAYLOR COLLEGE OF MEDICINE · PI LI, XIAOTAO · 2008 to 2011
$928k
RAT PUP HUDDLING: INTEGRATING MODELS AND EXPERIMENTSF32HD008188 · NICHD · INDIANA UNIVERSITY BLOOMINGTON · PI SCHANK, JEFFREY C · 1996 to 1998
–
NCI NIH HHS P30 CA125123NCI NIH HHS P30CA125123NCI NIH HHS R01 CA131914NCI NIH HHS R01CA131914NHLBI NIH HHS R01 HL051586NHLBI NIH HHS R01HL51586NICHD NIH HHS F32 HD008188NICHD NIH HHS HD8188NICHD NIH HHS R01 HD008188NIDDK NIH HHS P30 DK079638NIDDK NIH HHS P30-DK079638
6 · The paper itself

Abstract

The ubiquitin-proteasome and autophagy-lysosome systems are major proteolytic pathways, whereas function of the Ub-independent proteasome pathway is yet to be clarified. Here, we investigated roles of the Ub-independent REGγ-proteasome proteolytic system in regulating metabolism. We demonstrate that mice deficient for the proteasome activator REGγ exhibit dramatic autophagy induction and are protected against high-fat diet (HFD)-induced liver steatosis through autophagy. Molecularly, prevention of steatosis in the absence of REGγ entails elevated SirT1, a deacetylase regulating autophagy and metabolism. REGγ physically binds to SirT1, promotes its Ub-independent degradation, and inhibits its activity to deacetylate autophagy-related proteins, thereby inhibiting autophagy under normal conditions. Moreover, REGγ and SirT1 dissociate from each other through a phosphorylation-dependent mechanism under energy-deprived conditions, unleashing SirT1 to stimulate autophagy. These observations provide a function of the REGγ proteasome in autophagy and hepatosteatosis, underscoring mechanistically a crosstalk between the proteasome and autophagy degradation system in the regulation of lipid homeostasis.

Indexed as

AutophagyAnimalsAutoantigensCell LineDiet, High-FatFatty LiverHeLa CellsHep G2 CellsHumansLipid MetabolismMiceMice, KnockoutPhosphorylationProteasome Endopeptidase ComplexProtein BindingSirtuin 1AutoantigensKi antigenProteasome Endopeptidase ComplexSirt1 protein, mouseSirtuin 1Ubiquitin

Identifiers

PMID24011073
PMCPMC3813599
OpenAlexW2042349286

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.